We further show that c-MYC expression is enhanced in BL cells where Tat is expressed, and we demonstrate that this enhancement is partially as a result of transcriptional regulation of the c-MYC promoter, through the collaboration of Tat with AP-1 factors, and via AP-1 sites located within the c-MYC promoter. The gene discussed is JUNB; the disease is Burkitt lymphoma.